CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a minimally invasive treatment for retinal degenerative diseases, specifically Geographic Atrophy and Retinitis Pigmentosa. Utilizing the Everads Injection System, it aims to deliver stem cells directly to the retina, enhancing drug distribution and reducing side effects associated wi…
Retinal degenerative disease is a debilitating condition with a major impact on daily life.
This includes Geographic Atrophy(GA) - as a consequence of age-related macular degeneration (AMD) - and advanced Retinitis Pigmentosa (RP) - all characterized by photoreceptor loss.
In fact, they are the main causes of registered blindness.
In this regard, there are no currently effective treatments for patients suffering from GA a and RP, leaving approximately 2.6 million people across Europe and over 5…
EVERADS THERAPY LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
